haloperidol and 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride

haloperidol has been researched along with 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (30.77)18.2507
2000's8 (61.54)29.6817
2010's1 (7.69)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kobayashi, T; Matsuno, K; Mita, S; Nakata, K1
Kobayashi, T; Matsuno, K; Mita, S; Nakata, K; Okamoto, K; Senda, T1
Maurice, T; Privat, A1
Maurice, T; Privat, A; Su, TP1
Elsinga, PH; Ishiwata, K; Kawamura, K; Kobayashi, T; Senda, M; Tsukada, H; Vaalburg, W1
Horikomi, K; Karasawa, J; Takagi, K; Takahashi, S1
Ishiwata, K; Kawamura, K; Kiyosawa, M; Kobayashi, T; Matsuno, K; Mochizuki, M; Oda, K; Wang, WF1
Ishiwata, K; Kawamura, K; Kobayashi, T; Matsuno, K1
Allmon, RL; Gustafson, JL; Lever, JR; Lever, SZ; Xu, R1
Chihara, K; Ishii, K; Ishiwata, K; Kawamura, K; Kimura, Y; Naganawa, M; Oda, K; Okubo, Y; Sakata, M; Sasaki, T1
Chihara, K; Ishii, K; Ishiwata, K; Kimura, Y; Naganawa, M; Oda, K; Sakata, M1
Akhter, N; Kinuya, S; Mori, H; Nakajima, K; Ogawa, K; Shiba, K1
Brust, P; Cui, M; Deuther-Conrad, W; Jia, B; Jia, H; Li, D; Liu, B; Lu, J; Steinbach, J; Wang, X; Xie, Y1

Other Studies

13 other study(ies) available for haloperidol and 1-(3,4-dimethoxyphenethyl)-4-(3-phenylpropyl)piperazine dihydrochloride

ArticleYear
Enhancement of acetylcholine release by SA4503, a novel sigma 1 receptor agonist, in the rat brain.
    The Journal of pharmacology and experimental therapeutics, 1996, Volume: 279, Issue:1

    Topics: Acetylcholine; Animals; Brain; Haloperidol; Male; Phenazocine; Piperazines; Rats; Rats, Wistar; Receptors, sigma; Tacrine; Tetrodotoxin

1996
SA4503, a novel cognitive enhancer, with sigma 1 receptor agonistic properties.
    Behavioural brain research, 1997, Volume: 83, Issue:1-2

    Topics: Acetylcholine; Aminoacridines; Animals; Avoidance Learning; Brain Chemistry; Catalepsy; Cholinergic Antagonists; Cholinesterase Inhibitors; Cognition; Dopamine Antagonists; Haloperidol; In Vitro Techniques; Microdialysis; Nootropic Agents; Parasympathetic Nervous System; Piperazines; Rats; Receptors, sigma; Scopolamine

1997
SA4503, a novel cognitive enhancer with sigma1 receptor agonist properties, facilitates NMDA receptor-dependent learning in mice.
    European journal of pharmacology, 1997, Jun-05, Volume: 328, Issue:1

    Topics: Amnesia; Analysis of Variance; Animals; Avoidance Learning; Cognition; Disease Models, Animal; Dizocilpine Maleate; Dopamine Antagonists; Drug Interactions; Excitatory Amino Acid Antagonists; Haloperidol; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Maze Learning; Mice; NG-Nitroarginine Methyl Ester; Nitric Oxide; Piperazines; Progesterone; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Spatial Behavior

1997
Sigma1 (sigma 1) receptor agonists and neurosteroids attenuate B25-35-amyloid peptide-induced amnesia in mice through a common mechanism.
    Neuroscience, 1998, Volume: 83, Issue:2

    Topics: Amnesia; Amyloid beta-Peptides; Analgesics, Opioid; Animals; Antipsychotic Agents; Avoidance Learning; Dehydroepiandrosterone; Haloperidol; Injections, Intraventricular; Male; Mice; Morpholines; Pentazocine; Peptide Fragments; Piperazines; Pregnenolone; Progesterone; Receptors, sigma

1998
Synthesis and evaluation of [18F]fluoroethyl SA4503 as a PET ligand for the sigma receptor.
    Synapse (New York, N.Y.), 2002, Mar-15, Volume: 43, Issue:4

    Topics: Animals; Autoradiography; Binding, Competitive; Brain; Dopamine Antagonists; Fluorine Radioisotopes; Haloperidol; Ligands; Lipid Metabolism; Macaca mulatta; Male; Mice; Neurons; Nootropic Agents; Piperazines; Rats; Rats, Wistar; Receptors, sigma; Tomography, Emission-Computed; Viscera

2002
Effects of sigma(1) receptor ligand MS-377 on D(2) antagonists-induced behaviors.
    Pharmacology, biochemistry, and behavior, 2002, Volume: 73, Issue:3

    Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Behavior, Animal; Catalepsy; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Female; Haloperidol; Male; Mice; Nootropic Agents; Phenazocine; Piperazines; Pyridines; Pyrrolidines; Rats; Receptors, sigma; Serotonin Antagonists; Sigma-1 Receptor; Sulpiride; Tartrates

2002
Visualization of sigma1 receptors in eyes by ex vivo autoradiography and in vivo positron emission tomography.
    Experimental eye research, 2002, Volume: 75, Issue:6

    Topics: Animals; Autoradiography; Brain; Ciliary Body; Eye; Haloperidol; Iris; Ligands; Male; Piperazines; Rabbits; Rats; Rats, Wistar; Receptors, sigma; Retina; Tissue Distribution; Tomography, Emission-Computed

2002
Sigma1 and dopamine D2 receptor occupancy in the mouse brain after a single administration of haloperidol and two dopamine D2-like receptor ligands.
    Nuclear medicine and biology, 2003, Volume: 30, Issue:4

    Topics: Animals; Benzamides; Brain; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Haloperidol; Injections, Intraperitoneal; Ligands; Male; Mice; Nootropic Agents; Piperazines; Raclopride; Receptors, Dopamine D2; Receptors, sigma

2003
Sigma1 and sigma2 receptor binding affinity and selectivity of SA4503 and fluoroethyl SA4503.
    Synapse (New York, N.Y.), 2006, Volume: 59, Issue:6

    Topics: Animals; Autoradiography; Binding, Competitive; Brain; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluorine Radioisotopes; Guanidines; Guinea Pigs; Haloperidol; Inhibitory Concentration 50; Ligands; Male; Narcotic Antagonists; Pentazocine; Piperazines; Protein Binding; Radioligand Assay; Radiopharmaceuticals; Receptors, sigma; Structure-Activity Relationship

2006
A feasibility study of [11C]SA4503-PET for evaluating sigmal receptor occupancy by neuroleptics: the binding of haloperidol to sigma1 and dopamine D2-like receptors.
    Annals of nuclear medicine, 2006, Volume: 20, Issue:8

    Topics: Adult; Antipsychotic Agents; Brain; Dopamine Antagonists; Feasibility Studies; Haloperidol; Humans; Male; Nootropic Agents; Piperazines; Positron-Emission Tomography; Protein Binding; Receptors, Dopamine D2; Receptors, sigma; Time Factors

2006
Mapping of human cerebral sigma1 receptors using positron emission tomography and [11C]SA4503.
    NeuroImage, 2007, Volume: 35, Issue:1

    Topics: Adult; Biotransformation; Brain; Brain Chemistry; Brain Mapping; Chromatography, High Pressure Liquid; Data Interpretation, Statistical; Dopamine Antagonists; Haloperidol; Humans; Image Processing, Computer-Assisted; Male; Nonlinear Dynamics; Piperazines; Positron-Emission Tomography; Radioligand Assay; Radiopharmaceuticals; Receptors, sigma; Sigma-1 Receptor

2007
In vivo characterization of radioiodinated (+)-2-[4-(4-iodophenyl) piperidino] cyclohexanol as a potential sigma-1 receptor imaging agent.
    Nuclear medicine and biology, 2007, Volume: 34, Issue:6

    Topics: Animals; Autoradiography; Biotransformation; Brain; Central Nervous System; Chemical Phenomena; Chemistry, Physical; Cyclohexanols; Haloperidol; Iodine Radioisotopes; Isotope Labeling; Male; Narcotic Antagonists; Nootropic Agents; Pentazocine; Piperazines; Piperidines; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Receptors, sigma; Sigma-1 Receptor; Stereoisomerism; Tissue Distribution

2007
Novel cyclopentadienyl tricarbonyl (99m)tc complexes containing 1-piperonylpiperazine moiety: potential imaging probes for sigma-1 receptors.
    Journal of medicinal chemistry, 2014, Aug-28, Volume: 57, Issue:16

    Topics: Animals; Brain; Brain Neoplasms; Cell Line, Tumor; Glioma; Haloperidol; Ligands; Male; Mice, Inbred ICR; Molecular Imaging; Molecular Probes; Organotechnetium Compounds; Piperazines; Prostatic Neoplasms; Receptors, sigma; Sigma-1 Receptor; Structure-Activity Relationship; Technetium; Tissue Distribution

2014